Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $348,661 | 78 | 50.0% |
| Consulting Fee | $123,013 | 45 | 17.6% |
| Compensation for serving as faculty or as a speaker for a medical education program | $82,000 | 27 | 11.8% |
| Travel and Lodging | $67,144 | 181 | 9.6% |
| Education | $46,958 | 38 | 6.7% |
| Food and Beverage | $23,491 | 561 | 3.4% |
| Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program | $4,900 | 3 | 0.7% |
| Honoraria | $1,000 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $160,895 | 80 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $138,054 | 212 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $109,445 | 90 | $0 (2024) |
| Lucid Diagnostics Inc. | $108,114 | 157 | $0 (2023) |
| ABBVIE INC. | $74,041 | 134 | $0 (2024) |
| Olympus Corporation of the Americas | $49,696 | 87 | $0 (2022) |
| Phathom Pharmaceuticals, Inc. | $19,115 | 24 | $0 (2024) |
| Exact Sciences Corporation | $13,581 | 29 | $0 (2024) |
| RedHill Biopharma Inc. | $7,604 | 11 | $0 (2022) |
| US ENDOSCOPY | $4,477 | 6 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $189,404 | 230 | ABBVIE INC. ($53,096) |
| 2023 | $211,397 | 190 | GENZYME CORPORATION ($100,612) |
| 2022 | $142,982 | 154 | Lucid Diagnostics Inc. ($59,471) |
| 2021 | $95,130 | 200 | Lucid Diagnostics Inc. ($48,143) |
| 2020 | $16,968 | 29 | Olympus Corporation of the Americas ($10,234) |
| 2019 | $13,460 | 46 | Olympus Corporation of the Americas ($11,062) |
| 2018 | $13,618 | 43 | Olympus Corporation of the Americas ($12,539) |
| 2017 | $14,208 | 42 | Olympus Corporation of the Americas ($11,922) |
All Payment Transactions
934 individual payment records from CMS Open Payments — Page 1 of 38
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.05 | General |
| Category: Gastroenterology | ||||||
| 12/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $9.39 | General |
| Category: Gastroenterology | ||||||
| 12/30/2024 | ABBVIE INC. | CREON (Drug) | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/23/2024 | ABBVIE INC. | — | Travel and Lodging | In-kind items and services | $106.84 | General |
| 12/18/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $17.15 | General |
| Category: Gastroenterology | ||||||
| 12/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $6.88 | General |
| Category: Gastroenterology | ||||||
| 12/16/2024 | ABBVIE INC. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| 12/12/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | ABBVIE INC. | CREON (Drug) | Travel and Lodging | In-kind items and services | $127.59 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/12/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $29.82 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/11/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $10.18 | General |
| Category: Gastroenterology | ||||||
| 12/10/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,954.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/07/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $1,397.50 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/06/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $628.78 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/05/2024 | ABBVIE INC. | CREON (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,550.00 | General |
| Category: ENDOCRINOLOGY | ||||||
| 12/05/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $92.10 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/04/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Travel and Lodging | Cash or cash equivalent | $48.76 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $13.50 | General |
| Category: Gastroenterology | ||||||
| 11/27/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $5.88 | General |
| Category: Gastroenterology | ||||||
| 11/26/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $263.48 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $9,954.00 | General |
| Category: Immunology | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,400.00 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $391.84 | General |
| Category: Immunology | ||||||
| 11/20/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $296.95 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 603 | 724 | $916,950 | $80,440 |
| 2022 | 13 | 702 | 812 | $891,553 | $79,681 |
| 2021 | 14 | 589 | 697 | $773,560 | $72,910 |
| 2020 | 13 | 499 | 572 | $477,899 | $46,370 |
All Medicare Procedures & Services
53 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 109 | 171 | $94,050 | $18,637 | 19.8% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2023 | 23 | 24 | $130,992 | $16,039 | 12.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 68 | 89 | $66,305 | $13,489 | 20.3% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 37 | 37 | $39,405 | $7,152 | 18.1% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2023 | 52 | 54 | $59,022 | $6,112 | 10.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 30 | 30 | $29,910 | $4,075 | 13.6% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2023 | 33 | 33 | $153,450 | $3,911 | 2.5% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2023 | 14 | 14 | $72,464 | $3,072 | 4.2% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2023 | 34 | 36 | $134,568 | $3,051 | 2.3% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $69,750 | $1,907 | 2.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 124 | 152 | $3,134 | $1,277 | 40.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Facility | 2023 | 15 | 15 | $56,070 | $1,066 | 1.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 49 | 54 | $7,830 | $652.68 | 8.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 117 | 174 | $95,700 | $18,622 | 19.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 73 | 90 | $67,050 | $14,434 | 21.5% |
| 91110 | Imaging of digestive tract done from the inside of the digestive tract | Office | 2022 | 13 | 13 | $70,954 | $9,928 | 14.0% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 44 | 44 | $46,860 | $8,424 | 18.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 53 | 53 | $52,841 | $6,822 | 12.9% |
| 45385 | Removal of polyps or growths of large bowel using an endoscope with mechanical snare | Office | 2022 | 28 | 28 | $144,928 | $6,644 | 4.6% |
| 46600 | Diagnostic exam of anus using an endoscope | Office | 2022 | 38 | 42 | $45,906 | $5,067 | 11.0% |
| 45380 | Biopsy of large bowel using a flexible endoscope | Office | 2022 | 43 | 43 | $199,950 | $3,434 | 1.7% |
| 43239 | Biopsy of esophagus, stomach, and/or upper small bowel using a flexible endoscope | Office | 2022 | 40 | 40 | $149,520 | $3,395 | 2.3% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2022 | 14 | 14 | $2,030 | $968.22 | 47.7% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2022 | 70 | 74 | $10,730 | $945.84 | 8.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 156 | 184 | $3,680 | $545.22 | 14.8% |
About David Poppers, MD, PHD
David Poppers, MD, PHD is a Gastroenterology healthcare provider based in New York, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/19/2007. The National Provider Identifier (NPI) number assigned to this provider is 1063617165.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, David Poppers, MD, PHD has received a total of $697,166 in payments from pharmaceutical and medical device companies, with $189,404 received in 2024. These payments were reported across 934 transactions from 37 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($348,661).
As a Medicare-enrolled provider, Poppers has provided services to 2,393 Medicare beneficiaries, totaling 2,805 services with total Medicare billing of $279,402. Data is available for 4 years (2020–2023), covering 53 distinct procedure/service records.
Practice Information
- Specialty Gastroenterology
- Location New York, NY
- Active Since 06/19/2007
- Last Updated 03/30/2021
- Taxonomy Code 207RG0100X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1063617165
Products in Payments
- DUPIXENT (Biological) $265,937
- XIFAXAN (Drug) $70,023
- ESOCHECK CCD CELL COLLECTION DEVICE (Device) $58,854
- CREON (Drug) $56,516
- EVIS EXERA (Device) $35,830
- TRULANCE (Drug) $34,888
- PLENVU (Drug) $33,015
- VOQUEZNA (Drug) $19,115
- Cologuard Collection Kit (Device) $13,581
- EndoCapsule (Device) $10,912
- Talicia (Drug) $7,582
- Endocuff Vision (Device) $2,466
- LINZESS (Drug) $1,535
- GELPOINT PATH (Device) $1,223
- Olympus (Device) $1,107
- GELPOINT VPATH (Device) $1,000
- Endocuff Devices (Device) $745.10
- CIBINQO (Drug) $610.80
- Single Use Biliary Stent V (Device) $515.00
- Trulance (Drug) $492.99
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Gastroenterology Doctors in New York
Arthur Kornbluth, Md, MD
Gastroenterology — Payments: $2.4M
Dr. David Carr-Locke, Md Frcp Facg Masge, MD FRCP FACG MASGE
Gastroenterology — Payments: $2.3M
Jean-Frederic Colombel, M.d, M.D
Gastroenterology — Payments: $1.1M
Dr. Bruce Sands, Md, MD
Gastroenterology — Payments: $1.0M
Ellen Scherl, Md, MD
Gastroenterology — Payments: $880,329
Sonal Kumar, Md, MD
Gastroenterology — Payments: $769,554